Compound ID | 2041
Synonym(s): Zagam | AT-4140
Class: Fluoroquinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Binds to type II topoisomerases, gyrase and topoisomerase IV and thus, inhibits DNA cleavage and ligation reactions. It kills bacterial cells by increasing the concentration of enzyme–DNA cleavage complexes, thereby inhibiting cell replication. |
| Description: | Synthetic quinoline derivative. |
| Institute where first reported: | Mylan |
| Year first mentioned: | 1985 |
| Highest developmental phase: | Approved by FDA in 1996 |
| Development status: | Discontinued in most countries |
| Reason Dropped: | Phototoxicity and QTc prolongation |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/60464 |
| Guide to Pharmacology: | sparfloxacin |
| Citations: |
|